ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

138
Analysis
Health CareIndia
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
Refresh
05 Nov 2020 18:13

Gland Pharma IPO - High on Growth but Low on Details

Gland Pharma aims to raise around US$900m in what would be one of India’s largest IPOs in 2020. Fosun Pharmaceutical  bought a 74% stake in the...

Logo
430 Views
Share
28 Oct 2020 13:51

Sensex Index Rebalance Preview: Take Profit on Strong Outperformance

With the review period for the Sensex almost complete, we still see DRRD as a high probability inclusion and ONGC as a deletion. With DRRD...

Logo
327 Views
Share
18 Sep 2020 22:34
Logo
509 Views
Share
bullishVedanta Ltd
13 Sep 2020 07:53

Last Week in Event SPACE: Vedanta, Cardinal Res., Japan Retail Fund, HSBC, Opticomm, Tiffany/LVMH

Last Week in Event SPACE ...   Plus, other events, CCASS movements and Mood Spins. (This insight covers specific insights & comments...

Logo
374 Views
Share
06 Sep 2020 14:25

Sensex Index Rebalance Preview: Early Look Sees One Change, Maybe Two

The S&P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float weighted market cap...

Logo
667 Views
Share
x